Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
03/2000
03/09/2000CA2249657A1 Novel compounds
03/08/2000EP0983767A1 Preventives or remedies for sensitized t cell-related diseases containing il-6 antagonists as the active ingredient
03/08/2000EP0983380A1 Methods for treating bipolar mood disorder associated with markers on chromosome 18q
03/08/2000EP0983361A1 Bacterial pheromones and uses therefor
03/08/2000EP0983359A1 DETECTION OF LOSS OF THE WILD-TYPE $i(hu)BUB1 GENE
03/08/2000EP0983358A1 New human dp1 homolog
03/08/2000EP0983356A1 Smad2 phosphorylation and interaction with smad4
03/08/2000EP0983258A1 N-hydroxy 4-sulfonyl butanamide compounds
03/08/2000EP0983257A1 Aromatic sulfonyl alpha-cycloamino hydroxamic acid compounds
03/08/2000EP0983222A1 Pharmaceutical agents for the treatment of cerebral amyloidosis
03/08/2000EP0983091A1 Obesity protein formulations
03/08/2000EP0983086A1 pH-SENSITIVE LIPOSOMES AND OTHER TYPES OF ENCAPSULATED VACCINES CONTAINING IMMUNOMODULATORS, AND METHODS FOR MAKING AND USING SAME
03/08/2000EP0983085A2 Compositions and means for the treatment of burns and other cutaneous traumas
03/08/2000EP0983078A1 SIALOADHESIN FAMILY 4 cDNA
03/08/2000EP0983074A2 Non-myeloablative tolerogenic treatment
03/08/2000EP0983073A1 Ophthalmic compositions containing a divalent salt and a non steroidal anti-inflammatory drugs as a precipitate
03/08/2000EP0983062A1 Method for increasing the concentration of ascorbic acid in brain tissues of a subject
03/08/2000EP0983054A1 Hair growth compositions and uses
03/08/2000EP0983037A1 Antifungal nail lacquer and method using same
03/08/2000EP0982988A1 Substantially pure zonulin, a physiological modulator of mammalian tight junctions
03/08/2000CN1246868A Melanocortins
03/08/2000CN1246798A Use of gastrointestinal lipase inhibitors
03/08/2000CN1246793A Method and compositions for treating allergic asthma and other diseases using descartoethoxyloratadine
03/08/2000CN1246791A Compositions and methods for treating or preventing inflammatory diseases
03/07/2000US6034219 Human macrophage antigen
03/07/2000US6034148 Energy absorbing foams
03/07/2000US6034122 Combined use of diclofenac and tribenoside to treat osteoarthritis
03/07/2000US6034117 Administering acetyl choline esterase inhibitor
03/07/2000US6034116 Mixtures of substituted benzimidazoles with polyether antibiotics or synthetic coccidiostats as agents for use against parasitic protozoa
03/07/2000US6034110 Method for preventing onset of restenosis after angioplasty employing an RXR-specific retinoid and a PPARγ ligand
03/07/2000US6034109 Method for protection of heart by limiting metabolic and ionic abnormalities developed during ischemia following ischemia or resulting from ischemia
03/07/2000US6034105 Alteration of circadian rhythmicity with a tachykinin antagonist
03/07/2000US6034080 Alzheimer's disease
03/07/2000US6034066 Cysteine protease inhibitors for use in treatment of IGE mediated allergic diseases
03/07/2000US6034063 Human phosphatidylinositol transfer protein gamma
03/07/2000US6033682 S(+) desmethylselegiline and its use in therapeutic methods and pharmaceutical compositions
03/07/2000US6033662 Oxygen activatable formulations for disinfection or sterilization
03/07/2000CA2136706C Process for controlling adiposity and compositions for use therein
03/07/2000CA2013966C Active specific immunotherapy of adenocarcinomas producing immunosuppressive mucins
03/02/2000WO2000011478A1 Assays, methods and means for modulating nuclear localisation
03/02/2000WO2000011204A2 Homer interacting proteins
03/02/2000WO2000011195A1 C-myc is activated by beta-catenin and tcf-4
03/02/2000WO2000011194A1 Cyclophilin-type peptidyl-prolyl cis/trans isomerase
03/02/2000WO2000011191A2 Tpl-2/cot kinase and methods of use
03/02/2000WO2000011174A1 Human il-1 epsilon dna and polypeptides
03/02/2000WO2000011171A2 Human rna-associated proteins
03/02/2000WO2000011170A1 14400 receptor, a g-protein coupled receptor
03/02/2000WO2000011169A2 Human cell signaling proteins (csig)
03/02/2000WO2000011167A2 Nucleic acids encoding a functional human purinoreceptor p2x2 and methods of producing and use thereof
03/02/2000WO2000011166A1 14274 receptor, a g-protein coupled receptor related to the edg receptor family
03/02/2000WO2000011160A1 Grip, human adapter protein related to the grb2 family member
03/02/2000WO2000011000A2 New compounds
03/02/2000WO2000010999A2 New compounds
03/02/2000WO2000010981A1 Quinazoline derivatives
03/02/2000WO2000010611A2 Drug targeting
03/02/2000WO2000010609A1 Targeting of molecules to large vessel endothelium using epcr
03/02/2000WO2000010600A2 Activation and protection of t-cells (cd4+ and cd8+) using an h¿2? receptor agonist and other t-cell activating agents
03/02/2000WO2000010598A2 Recombinant botulinium toxin for the treatment of mucus hypersecretion
03/02/2000WO2000010594A1 The use of glial cell line-derived neurotrophic factor family-related compounds for regulating spermatogenesis and for preparing male contraceptives
03/02/2000WO2000010588A2 Epidermal growth factor receptor antagonists for treating hypersecretion of mucus in the lungs
03/02/2000WO2000010583A1 Human histone deacetylase gene hd4
03/02/2000WO2000010582A2 Probiotic, lactic acid-producing bacteria and uses thereof
03/02/2000WO2000010576A1 Method of producing means for treating the human body
03/02/2000WO2000010565A1 Growth hormone secretagogues
03/02/2000WO2000010551A2 Methods of using and compositions comprising dopamine reuptake inhibitors
03/02/2000WO2000010550A2 Reduction of surfactant inactivation in pulmonary surfactant therapy
03/02/2000WO2000010549A1 Regulation of substrate activity
03/02/2000WO2000010545A2 Use of substance p antagonists for the treatment of chronic fatigue syndrome and/or fibromyalgia and use of nk-1 receptor antagonists for the treatment of chronic fatigue syndrome
03/02/2000WO2000010533A2 Compositions and methods for treating intracellular infections
03/02/2000WO2000010529A1 Oral liquid mucoadhesive compositions
03/02/2000WO2000010526A2 New oral formulation for 5-ht4 agonists or antagonists
03/02/2000WO2000010391A1 The use of adenosine a3 receptor antagonists to inhibit tumor growth
03/02/2000WO1999065513A3 Pharmaceutical compositions for the treatment of helicobacter pylori-associated disorders
03/02/2000WO1999063938A9 Composition and method for prevention and treatment of cardiopulmonary and renal failure or damage associated with ischemia, endotoxin release, ards or brought about by administration of certain drugs
03/02/2000WO1999061614A3 Human socs proteins
03/02/2000WO1999058558A3 Cell signaling proteins
03/02/2000WO1999055367A9 INTERNALIZING ErbB2 ANTIBODIES
03/02/2000WO1999042596A3 Phosphodiesterase 10
03/02/2000WO1999042088A3 Method for the treatment of diseases or disorders of the inner ear
03/02/2000DE19839491A1 Verfahren zur Markierung von Biopolymeren mit Isotopen Methods for labeling of biopolymers with isotopes
03/02/2000DE19839443A1 Pharmaceutical and dietetic product contains quaternary ammonium compound and/or S-adenosyl-methionine, useful for treatment of oxygen deficiency and energy metabolism disorders and NSAID side effects
03/02/2000DE19838848A1 Pyrrolizidinalkaloidfreie Petasites enthaltende Zusammensetzung Pyrrolizidinalkaloidfreie Petasites containing composition
03/02/2000CA2342503A1 Quinazoline derivatives
03/02/2000CA2342162A1 Drug targeting
03/02/2000CA2341742A1 Activation and protection of t-cells (cd4+ and cd8+) using an h2 receptor agonist and other t-cell activating agents
03/02/2000CA2341586A1 Targeting of molecules to large vessel endothelium using epcr
03/02/2000CA2340785A1 Cyclophilin-type peptidyl-prolyl cis/trans isomerase
03/02/2000CA2340459A1 C-myc is activated by beta-catenin and tcf-4
03/02/2000CA2340457A1 14400 receptor, a g-protein coupled receptor
03/02/2000CA2340334A1 14274 receptor, a g-protein coupled receptor related to the edg receptor family
03/02/2000CA2340277A1 Human rna-associated proteins
03/02/2000CA2339871A1 Nucleic acids encoding a functional human purinoreceptor p2x2 and methods of producing and use thereof
03/02/2000CA2339860A1 Human cell signaling proteins (csig)
03/02/2000CA2339537A1 Regulation of substrate activity
03/02/2000CA2339372A1 New compounds
03/02/2000CA2339286A1 New compounds
03/02/2000CA2339036A1 Tpl-2/cot kinase and methods of use
03/02/2000CA2338837A1 Assays, methods and means for modulating nuclear localisation
03/02/2000CA2338644A1 The use of glial cell line-derived neurotrophic factor family-related compounds for regulating spermatogenesis and for preparing male contraceptives
03/02/2000CA2245254A1 Glycoside shampoo for treating psoriasis
1 ... 986 987 988 989 990 991 992 993 994 995 996 997 998 999 1000 1001 1002 1003 1004 1005 1006 ... 1151